WO2004089087A1 - 皮膚外用剤組成物 - Google Patents
皮膚外用剤組成物 Download PDFInfo
- Publication number
- WO2004089087A1 WO2004089087A1 PCT/JP2004/004826 JP2004004826W WO2004089087A1 WO 2004089087 A1 WO2004089087 A1 WO 2004089087A1 JP 2004004826 W JP2004004826 W JP 2004004826W WO 2004089087 A1 WO2004089087 A1 WO 2004089087A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- propanediol
- purified water
- phase
- acid
- diol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/04—Oxygen or sulfur attached to an aliphatic side-chain of a carbocyclic ring system
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/02—Acyclic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
- A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
- A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
- A23L3/3463—Organic compounds; Microorganisms; Enzymes
- A23L3/3481—Organic compounds containing oxygen
- A23L3/349—Organic compounds containing oxygen with singly-bound oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/345—Alcohols containing more than one hydroxy group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/02—Preparations containing skin colorants, e.g. pigments
- A61Q1/10—Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/12—Face or body powders for grooming, adorning or absorbing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/001—Preparations for care of the lips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
Definitions
- the present invention relates to a skin external preparation composition and an antibacterial agent. More specifically, it has excellent antibacterial activity against a wide range of microorganisms that can be preferably used in skin external preparation compositions, cleansers, foods, daily necessities, etc.
- the present invention relates to a skin external preparation composition and an antibacterial agent, which have significantly improved usability and safety while ensuring their properties.
- Creams including ointments
- sunscreens including ointments
- foundations oils, packs, stones (including medicinal stones)
- body soaps including lipsticks, nail cosmetics, eyebrows, cosmetics, perfumes, facial cleansers, oral products ( Toothpaste, mouthwash, etc.), deodorant
- antibacterial processing of textile products sheets, clothes, etc.
- food packaging films synthetic resins, wood, daily necessities, various forms of oral drugs, sanitary cotton, wet tissue wipes, disinfectants Oral composition (gum, candy, etc.), fish paste products such as kamaboko, chikuwa, livestock products such as sausage, ham, Western confectionery, Japanese confectionery, raw noodles, yuden noodles , Chinese noodles, udon, buckwheat, spaghetti 6
- noodles such as tea, soy sauce, sauces, seasonings such as sauces, side dishes, juices and soups.
- sorbic acid, dehydroacetic acid and its salts, and paraoxybenzoic acid derivatives are often used as antibacterial agents for foods, pharmaceuticals, cosmetics, etc.
- the upper limit of sorbic acid and its salts in food is 0.2%, and dehydroacetic acid and its salts are cheese, And Margarine, and the upper limit of the mixing ratio of methyl sodium methyl laoxybenzoate in cosmetics was 1.0%).
- the invasion of microorganisms is controlled by physical methods in the skin or mucous membranes of the living body or by chemical methods such as the distribution of bactericidal substances or mucus.
- infectious symptoms will appear in the living organism, such as infectious dermatitis such as Staphylococcus aureus, food poisoning, sepsis, and Bacillus subtilis.
- infectious dermatitis such as Staphylococcus aureus
- food poisoning sepsis
- Bacillus subtilis Conjunctivitis due to conjunctivitis, ulceris, Escherichia coli urinary tract infection, diarrhea, etc., periodontal disease due to actinobacillus, etc., tooth decay due to bacillus protozoa, and bacillus dysbiosis.
- There is a risk of causing various symptoms such as pimples caused by makness, dandruff fungus (Hytirosho.
- an object of the present invention is to provide a skin external preparation composition that satisfies both usability and safety while ensuring sufficient preservation.
- Another object of the present invention is to provide an antibacterial and antiseptic effect against infectious diseases and diseases caused by microorganisms such as bacteria, yeasts and molds, that is, an effect of disinfecting or preventing propagation over time, and The purpose is to provide a safe antibacterial agent even when used in various fields.
- a skin external preparation composition comprising Is done.
- R represents a benzyl group or a phenyl group.
- an antibacterial agent comprising the diol compound represented by the formula (I), ( ⁇ ), (III) or (IV) or a derivative thereof.
- R represents a pendyl group or a phenyl group.
- the present inventors have found that the dial compounds of the formulas (I) to (IV) or derivatives thereof have a strong antibacterial and antiseptic effect against various microorganisms, and It has been confirmed that it is safe to use it, and it has been found that it is very effective to apply it to various fields as a new antibacterial agent. Thus, the present invention has been completed.
- the present inventors also have an antibacterial and antiseptic effect against infectious diseases and diseases caused by microorganisms such as bacteria, yeasts, and molds, that is, they have an effect of disinfecting or preventing propagation over time and have various effects.
- microorganisms such as bacteria, yeasts, and molds
- the diol compounds represented by the above formulas (I) to (IV) or derivatives thereof have strong antibacterial properties against various microorganisms. ⁇ Confirmed that it has an antiseptic effect and is safe for humans or animals, discovered that it is very effective to apply it to various fields as a new antibacterial agent, and completed the present invention Reached.
- the 3-hexyne-1,2-diol of the above formula (1) used in the present invention is a known substance, but is a novel use as an antibacterial agent.
- the 3-hexyne-1,2-diol used in the present invention can be easily produced from acetylene and acetylaldehyde. Also, for example, It is commercially available from Tokyo Chemical Industry Co., Ltd., Kanto Chemical Co., Ltd., ALDRI CH, etc., and can be easily obtained.
- the 3-hexyne-1,2,5-diol used in the present invention may be an optically active form, a racemic form, a meso form, or a mixture thereof.
- the glycerin derivative of the formula (II) used in the present invention is a known substance, but has a novel use as an antibacterial agent.
- This glycerin derivative can be produced by a general synthesis method. For example, it can be easily produced from halohydrins such as glycidol, glycerin, and chlorohydrin-bromohydrin and phenol or benzyl alcohol. Alternatively, it can be obtained by producing vandalididyl ether / rebenzyl glycidyl ether and then hydrolyzing it.
- 3-Phenoxy-1,2-propanediol is commercially available, for example, from Tokyo Chemical Industry Co., Ltd.
- 3-benzyloxy-1,2-propanediol is commercially available, for example, from Sigma, etc., and can be easily obtained.
- the glycerin derivative used in the present invention may be any of an optically active substance, a racemate, and a mixture thereof.
- 3-phenoxy-1,2-propanediol and 3-benzyloxy-1,2-propanediol may be used alone or in any combination.
- 2,2-Dimethyl-1-phenyl-1,3-propanediol of the above formula (III) used in the present invention is a known substance, but is a novel use as an antibacterial agent.
- the 2,2-dimethyl-1-phenyl-1,3-propanediol can be produced by a general synthesis method.
- Benzaldehyde and isobutyl aldehyde can be easily produced from benzaldehyde and isobutyl aldehyde. (For example, it can be obtained by the method of Wolterten Hoeve et al. (J. Org. Chem. 1985, 50, 450-8-41514).)
- —Dimethyl 1 F Enenyl-1,3-propanediol is commercially available from, for example, Aldrich and can be easily obtained.
- the 2,2-dimethyl-1-phenyl-1,3-propanediol used in the present invention may be any of an optically active substance, a racemic substance, and a mixture thereof.
- 2,4,7,9-Tetramethyl-5-decine-14,7-diol of the formula (IV) used in the present invention is a known substance, but is a novel use as an antibacterial agent.
- the 2,4,7,9-tetramethyl-15-decine-14,7-diol used in the present invention can be produced by a general synthesis method. For example, it can be synthesized using acetylene and 4-methyl-2-pentanone.
- 2,4,7,9-tetramethyl-5-decyne-1,4,7-diol is commercially available, for example, from Tokyo Chemical Industry Co., Ltd., and can be easily obtained.
- the 2,4,7,9-tetramethyl-15-decyne-4,71-diol used in the present invention may be any of an optically active substance, a racemate, and a mixture thereof.
- the antibacterial agent of the present invention can be incorporated into any skin external preparation composition.
- the antimicrobial agent of the present invention is a medical cleaning agent for disinfecting and cleaning medical instruments and affected parts; a household cleaning agent for disinfecting and cleaning dishes and the like; a cleaning agent for the food industry; food packaging films, fibers, and synthetic resins.
- the method of using the antibacterial agent of the present invention is not particularly limited, and it can be used for various objects. Can be applied. For example, methods of adding to the object, spraying, applying, dipping, impregnating, molding Normally adopted methods such as kneading at the time can be used as they are.
- the antibacterial agent of the present invention can be used as it is.
- the amount of the antibacterial agent when it is combined as an antibacterial agent varies depending on the product form and the expected degree of action, and is not particularly limited. ppm or more, preferably 10 ppm or more, more preferably 100 ppm to 500 ppm.
- the antibacterial agent of the present invention when incorporated into various compositions, various components generally used in foods, cosmetics, pharmaceuticals, quasi-drugs, etc., as long as the effects of the present invention are not impaired, for example, , Sugar, condensed milk, flour, chocolate, salt, pudose, chicken egg, putter, margarine, starch syrup, calcium, iron, seasoning, spices and oils (animal and vegetable oils, mineral oil, ester oil, wax oil, sili Corn oil, higher alcohols, phospholipids, fatty acids, etc., surfactants (anionic, cationic, amphoteric or nonionic surfactants), vitamins (vitamins A, vitamins) B group, folic acid, nicotinic acid, pantothenic acid, biotin, vitamin C group, vitamin D group, vitamin E group, other ferulic acid, V — oryzanol, etc.), ultraviolet rays Absorbent (P-aminobenzoic acid, anthranil, salicylic acid,
- Moisturizers (propylene glycol, 1,3-butylene glycol, polyethylene glycol, glycerin, 1,2-pentanediol, hexylene diol, condroitin sulfate and its salts, hyaluronic acid and its salts, (Sodium lactate, etc.) Others, lower alcohols, polyhydric alcohols, water-soluble polymers, pH regulators, preservatives and fungicides, coloring agents, fragrances, fresheners, stabilizers, animals and plants Extracts, animals, plant proteins and their degradation products, animals, plant polysaccharides and their degradation products, animal and plant glycoproteins and their degradation products, microbial culture metabolic components, blood flow enhancers, anti-inflammatory agents, anti-inflammatory Formulation, antiallergic agent, cell activator, amino acid and its salt, keratolytic agent, astringent, wound treatment, foam enhancer, oral agent, deodorant, deodorant, emulsifier, etc.
- the formulation of the antibacterial agent of the present invention in the external preparation composition for skin is optional, and may be formulated according to a conventional method.
- the antimicrobial agent of the present invention may be added to other compositions in any dosage form, and may be formulated in a conventional manner.
- oral drugs textile products (sheets, clothes, etc.) , Sanitary cotton, wipe wipe Non-woven fabrics such as paper for wiping and disinfecting cloth, and oral compositions (gum, candy, etc.) It can be used for general foods and drinks such as noodles, Chinese noodles, udon, buckwheat, etc., sauces, soy sauce, seasonings such as sauces, prepared foods, juices, soups, etc.
- compositions containing the antibacterial agent of the present invention is optional, and may be in the form of a solution, a cream, a paste, a gel, a gel, a foam, a solid, or a powder. Can be used.
- the antibacterial agent of the present invention comprising the diol compound of the formulas (I) to (IV) or a derivative thereof can be blended into any skin external preparation composition.
- the amount is different depending on the product form and is not particularly limited. However, considering the preservability of the external preparation for skin, it is usually required to be 0.01% by mass or more, preferably 0.1% by mass. That is all. More preferably, when the content is 1.0% by mass or more, the remarkable effect of the present invention is exhibited. Although it is difficult to particularly limit the upper limit of the composition due to the properties of the composition for external use on the skin, if the composition is excessively excessive, the usability such as stickiness is deteriorated, so that the upper limit is 10.0 mass. % Or less is preferred.
- any base can be used as long as it is a base of a normal skin external preparation composition. That is, liquid, gel, paste, emulsion, cream, and the like can be used.
- components that are usually incorporated into skin external preparation compositions such as powder components, liquid fats and oils, solid fats and oils, waxes, hydrocarbon oils, higher fatty acids, higher alcohols, ester oils, silicone oils, and anionic surfactants , Cationic surfactants, amphoteric surfactants, nonionic surfactants, humectants, water-soluble polymers, thickeners, coating agents, ultraviolet absorbers, sequestering agents, lower alcohols, polyhydric alcohols
- antibacterial action can be enhanced by adding common dihydric alcohols.
- the glycerin derivative of the formula (II) of the present invention is amphiphilic due to its structure, and is easily dissolved or compatible with water, alcohol, oil and the like, and is easily incorporated. In addition, there was an advantage that the usability was good.
- the components that can be blended in the skin external preparation composition containing the antibacterial agent of the present invention are specifically listed below, and a skin external preparation composition is prepared by blending one or more of the following components. Can be.
- the powder component examples include inorganic powders (for example, talc, porphyrin, mica, sericite, sericite, muscovite, phlogopite, synthetic mica, red mica, biotite, permikilite, magnesium carbonate, carbonate Calcium, aluminum silicate, barium silicate, calcium silicate, magnesium silicate, strontium silicate, metal tungstate, magnesium, silica, zeolite, parium sulfate, calcined sulfuric acid Secco II), calcium phosphate, fluorine apatite, hydroxyapatite, ceramic powder, metal stone (eg, zinc myristate, calcium palmitate, aluminum stearate), boron nitride, etc.); organic powder (For example, polyamide resin powder (Nylon powder) Ethylene powder, polymethyl methacrylate powder, benzoguanamine resin powder, polytetrafluoroethylene powder, cellulose powder, etc.); inorganic white pigments (eg, titanium dioxide,
- Red 222 Red 2 Organic pigments such as No. 28, Red No.405, Orange No.203, Orange No.204, Yellow No.205, Yellow No.401, and Blue No.404 Color No.3, Red No.104, Red No.106, Red No.227, Red No.230, Red No.401, Red No.505, Orange No.205, Yellow No.4, Yellow No. 5, Yellow No. 202, Yellow No. 203, Green No. 3 and Blue No. 1); natural pigments (eg, chlorophyll,] 3-carotene).
- natural pigments eg, chlorophyll,] 3-carotene
- liquid fats and oils examples include apogado oil, paki oil, macadamia nut oil, corn oil, olive oil, rapeseed oil, sesame oil, wheat germ oil, southern oil, castor oil, amaji oil, safflower oil, Cottonseed oil, soybean oil, peanut oil, teaseed oil, rice oil, hohopa oil, germ oil, triglycerin and the like.
- solid fats and oils examples include cocoa butter, coconut oil, hydrogenated coconut oil, palm oil, palm kernel oil, black wax kernel oil, hydrogenated oil, mokuro, and hydrogenated castor oil.
- wax examples include beeswax, candelilla roux, carnapa wax, lanolin, lanolin acetate, liquid lanolin, sugar cane wax, lanolin fatty acid isopropyl, hexyl laurate, and reduction.
- Hydrocarbon oils include, for example, liquid paraffin, ozokerite, squalane, pristane, halaffine, ceresin, squalene, decelin, microcrystalline wax, fisciatrop wax And the like.
- the higher fatty acids include, for example, lauric acid, myristic acid, palmitic acid, stearic acid, behedionic acid, oleic acid, pendecilenic acid, isostearic acid, linoleic acid, Linoleic acid, eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA) and the like.
- Higher alcohols include, for example, straight-chain alcohols (for example, benzyl alcohol, cetinole alcohol, stearyl alcohol, veinenorea noreconole, myristyl alcohol, suireinoreanore konore, seto stearyl alcohol) Branched-chain alcohols (for example, monostearylglycerin ether (patinorea / recol), 2-decyl tetradecinol, lanolin alcohol, cholesterol, phytosterol, hexyl dodecanol, isostearyl alcohol, otatyl dodecanol, etc.) And the like.
- straight-chain alcohols for example, benzyl alcohol, cetinole alcohol, stearyl alcohol, veinenorea noreconole, myristyl alcohol, seauinoreanore konore, seto stearyl alcohol
- Branched-chain alcohols for example, monostearylglycerin ether (pati
- Ester oils include isopropyl isopropyl myristate, cetyl octanoate, octyl dodecyl myristate, isopropyl isopropyl palmitate, butyl stearate, hexyl laurate, and myristate myristate.
- silicone oil examples include linear polysiloxanes (eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.); cyclic polysiloxanes (eg, otamethylcyclotetrasiloxane, decamethinoresic pentasiloxane, Dodecamethylcyclohexasiloxane, etc.), methyltrimethicone, silicone resin forming a three-dimensional network structure, silicone rubber, various modified polysiloxanes (amino-modified polysiloxane, polyether-modified polysiloxane, Alkyl-modified polysiloxane, fluorine-modified polysiloxane, etc.).
- linear polysiloxanes eg, dimethylpolysiloxane, methylphenylpolysiloxane, diphenylpolysiloxane, etc.
- anionic surfactants include fatty acid soaps (eg, sodium laurate, sodium palmitate, etc.); higher alkyl sulfates (eg, sodium lauryl sulfate) , Potassium lauryl sulfate etc.) Alkyl ether sulfates (eg POE-triethanolamine lauryl sulfate, POE-sodium sodium lauryl sulfate etc.); N-acyl sarcosine acid (eg , Higher fatty acid amide sulfonates (eg, N-myristyl N-methyl taurin sodium, coconut oil fatty acid methyl taurine sodium, ash oil fatty acid) Methyl taurine taurine sodium, lauryl methyl taurine sodium, lauryl methyl taurine Sulfosuccinates (for example, di-2-ethynolehexenoresnorelephoconodate sodium, monoradiomonoethanorelamidopolyoxyethylene
- alkyl trimethylan Monium salts eg, stearyl trimethylammonium chloride, lauric trimethylammonium chloride, etc.
- alkylpyridinium salts eg, cetylpyridinium chloride, etc.
- distearyl dimethylammonium dialkyldimethylamine Monium salt poly (N, N, -dimethyl-1,5-methylenepiperidinium) chloride; alkyl quaternary ammonium salt; alkyldimethylbenzylammonium salt; alkylisoquinodium salt; dialkylmolyphonium salt; chloride Benzalkonium; Benzene chloride and the like.
- amphoteric surfactant examples include imidazoline-based amphoteric surfactants (for example, 2-inddecyl_N, N, N— (hydroxyxyl carboxymethyl) -12-imidazolinna stream, 2 —Cocoyl-1—Imidazoli-Pemhydroxyl-1—One-pot lipoxishethyloxy 2-sodium salt etc.); Betaine-based surfactants (eg, 2-Heptadecyl_N—Fe-Roxyoxymethyl-N) — Hydroxyshetyl imidazolidinum betain, amidoamine-type amphoteric surfactant, lauryldimethylaminoacetonate betain, alkyl betain, amide betain, sulfobetaine, etc.) No.
- imidazoline-based amphoteric surfactants for example, 2-inddecyl_N, N, N— (hydroxyxyl carboxymethyl) -12-imidazolin
- lipophilic nonionic surfactant examples include sorbitan fatty acid esters (for example, sorbitan monooleate, sorbitan monoisostearate, sonolebitan monolaurate, sonolebitan monono, noremitate, sonorebita).
- sorbitan fatty acid esters for example, sorbitan monooleate, sorbitan monoisostearate, sonolebitan monolaurate, sonolebitan monono, noremitate, sonorebita.
- Glycerol polydaricerin fatty acids eg, monomonostearate, recbitan sesquioleate, sonolebitan trioleate, penter 2—diglycerol sorbitan di-ethynolehexenolate, tetra_2-diethylglycerol sorbitan
- Glycerin mono-cottonseed oil fatty acid glycerin monoernic acid, glycerin sesquioleate, glycerin monostearate, ⁇ , a'-glycerol pyroglutamate oleate, monostearic acid
- Propylene glycol fatty acid esters for example, propylene glycol monostearate
- hydrogenated castor oil derivatives glycerin alkyl ether, and the like.
- hydrophilic nonionic surfactant examples include POE-sorbitan fatty acid esters (for example, POE-sorbitan monooleate, POE-sorbitan monostearate, POE-sorbitan monooleate, POE-sorbitan monolate) POE sorbit fatty acid esters (eg, POE sorbit monolaurate, POE sorbitol monooleate, POE sorbitol monostearate, POE sorbitol monostearate, etc.); POE glycerin Fatty acid esters (for example, POE-monooleate such as POE-glycerin monostearate, POE-glycerin monoisostearate, POE-glycerin triisostearate); POE-fatty acid esters (eg, POE-distearate, POE) —Monodiolate, Gistely POE-alkyl ethers (for example, POE-lauryl ether, POE
- humectants examples include polyethylene glycol, propylene glycol, glycerin, 1,3-butylene glycol, xylyl, yl, sorbitol, maltitol, chondroitin sulfate, and hyanolone.
- Mucopolysaccharides such as acid, acetylated hyaluronic acid, and mucoitin sulfate and their salts, cholesterol 12-hydroxy cysteate, lactic acid, sodium lactate, dl-pyrrolidone carboxylate, trimethyldali Synth, diglycerin (EO) PO adducts, Isayopara extract, Cynospermum extract, melolot extract and the like.
- natural water-soluble polymers include, for example, plant polymers (for example, gum arabic, tragacanth, galactan, guar gum, carrageenan, pectin, carten, locust bingham, quince seed (malm ), Alge colloid (Katsuso extract), starch (rice)
- plant polymers for example, gum arabic, tragacanth, galactan, guar gum, carrageenan, pectin, carten, locust bingham, quince seed (malm ), Alge colloid (Katsuso extract), starch (rice)
- Microbial macromolecules for example, xanthan gum, dextran, succino glucan, gelangam, pullulan, etc.
- the semi-synthetic water-soluble polymers include, for example, starch-based polymers (for example, carboxymethyl starch, methylhydroxypropyl starch, etc.); and cellulosic polymers (methylsenorelose, ethylcellulose, methinoreoxyproxyl, etc.).
- Examples of the synthetic water-soluble polymer include vinyl polymers (for example, polyvinyl alcohol, polyvinyl methyl ether, polyvinylpyrrolidone, carboxyvinyl polymer, and alkyl-modified phenolic vinyl polymer).
- vinyl polymers for example, poly (ethylene glycol) 20,000, 40,000, 60,000 polyoxyethylene polyoxypropylene copolymers, etc.
- acryl polymers for example, sodium polyacrylate, Polyethyl acrylate, polyatomic amide, etc.
- polyethyleneimine cationic polymers.
- thickener other than the above-mentioned water-soluble polymer examples include, for example, aluminum magnesium silicate, bentonites, organically modified bentonites, hectrites, AlMg silicates (Vegum), and laboni. And silicic anhydride.
- the ultraviolet absorber examples include benzoic acid-based ultraviolet absorbers (for example, paraaminobenzoic acid (hereinafter abbreviated as PABA), PBA A monoglycerin ester, N, N-dipropoxy P ABA ethyl ester , N, N-diethoxy PABA ethyl ester, N, N_dimethyl PABA ethyl ester, N, N-dimethyl PABA ethyl ester, N, N-dimethyl PABA ethyl ester, etc.); salicylic acid UV absorbers (for example, Amyl salicylate, menthyl salicylate, homomethyl salicylate, octyl salicylate, fenyl salicylate, penzinole salicylate, p-isoprono, p-isophenyl, etc .; cinnamic acid ultraviolet absorbers (for example, Octyl cinnamate, ethyl-41 isoprop
- sequestering agents include 1-hydroxyxetane-1-1,1-diphosphonic acid, 1-hydroxyxetane-1-1,1-tetrasodium diphosphonate, sodium sodium edetate, and edetate Tridium sodium, tetrasodium edetate, sodium hexametarate, sodium citrate, sodium polyphosphate, metalate Sodium, gnoreconic acid, phosphoric acid, citric acid, ascorbic acid, succinic acid, edetic acid, sodium ethylenediamine hydroxitytyl triacetate, etc. No.
- Examples of the lower alcohol include ethanol, isopropanol, isobutyl alcohol, t-butyl alcohol and the like.
- polyhydric alcohol examples include dihydric alcohols (eg, ethylene glycol, propylene glycol, trimethylene glycol, 1,2-butylene glycol, 1,3-butylene glycol, tetramethylene glycol, , 3- butylene glycol, pentamethylene glycol, 2-butene-l, 4-diol, hexylene glycol, octylene glycol, etc .; trihydric alcohols (eg, glycerin, trimethylolpropane, etc.); tetravalent Alcohol (for example, pentaerythritol such as 1, 2, 6-hexanetriol); pentahydric alcohol (for example, xylitol); Hexavalent alcohol (for example, sorbitol, mannitol, etc.) Polyhydric alcohol polymers (eg, diethylene Liconole, dipropylene glycol, triethylene glycol, polypropylene glycol, tetraethylene glycol cornole, digly
- Ethylene glycol / lemonobutinooleate oleate Ethylene glycol phenolate ether acetate, Ethylene glycol oleoresin adsorbate, Ethylene glycol disuccinate, Diethylene glycol diole enolate enoate Rare Acetate, Diethylene Glyco Reno Butinorethenoate, Propylene Gly Reno Methino Reate, Tenorea Acetate, Propilendiary Co / Lemono Ethino Reno Reateno Acetate, Propylene Glycone Reno Propyl Ether Acetate, Pro Pyrene glycol monophenyl ether acetate, etc.); glycerin monoalkyl ether (eg, xyl alcohol, serakyl alcohol, patyl alcohol, etc.); sugar alcohol (example) For example, sorbitol tonole, manolet tonole, manole toriose, mannitol tonole
- Monosaccharides include, for example, trisaccharides (eg, D-glyceryl aldehyde, dihydroxyaceton); tetracarbon sugars (eg, D-erythrose, D-erythranolose, D— Pentoses (eg, L-arabinose, D-xylose, L-lyxose, D-arabinose, D_.
- trisaccharides eg, D-glyceryl aldehyde, dihydroxyaceton
- tetracarbon sugars eg, D-erythrose, D-erythranolose, D— Pentoses (eg, L-arabinose, D-xylose, L-lyxose, D-arabinose, D_.
- Oligosaccharides include, for example, sucrose, dantianose, umbelliferose, lactose, planteose, isoliqunoses, hi, hitrehalose, raffinose and the like.
- amino acids examples include neutral amino acids (eg, threonine, cystine, etc.); basic amino acids (eg, hydroxy lysine, etc.).
- amino acid derivatives include, for example, trimethyltilicin, glutathione, pyrrolidone carboxylic acid, and the like. You.
- the organic amines include, for example, monoethanolamine, jetanolamine, triethanolamine, morpholin, triisopropanolamine, 2-amino1-2-methyl-1,3— Puropanjio Honoré, 2- Ami no 2 Mechinore 1 one Purono ⁇ 0 Nord, and the like.
- polymer emulsion examples include acrylic resin emulsion, polyacrylic acid ester emulsion, acrylic resin solution, polyacrylalkyl ester emulsion, polyvinyl acetate resin emulsion, and natural rubber latex. .
- pH adjuster examples include buffers such as sodium lactate-lactate, sodium citrate-sodium citrate, sodium succinate-sodium succinate, and the like.
- vitamins examples include vitamins A, B1, B2, B6, C, E and derivatives thereof, pantothenic acid and derivatives thereof, biotin, and the like.
- antioxidants examples include tocopherols, dibutylhydroxytoluene, butylhydroxyesole, and gallic esters.
- Antioxidant aids include, for example, phosphoric acid, cunic acid, ascorbic acid, maleic acid, malonic acid, succinic acid, fumanoleic acid, cephalin, hexametaphosphate, phytic acid, ethylenediaminetetraacetic acid And the like.
- ingredients that can be blended include, for example, anti-inflammatory agents (eg, glycyrrhizic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, etc.); whitening agents (eg, placenta extract, Saxifrage extract, arbutin, tranexamic acid, potassium 4-methoxysalicylate, etc.); various extracts (for example, o Paper, Ku, Oren, Sikon, Peony, Assemblage, Perch, Sage, Bee, Carrot, Aloe, Zeniaoi, Iris, Grapes, Yokinin, Hetima, Lily, Saffron, Senkiyu, Shoukiyu, Otogiri Soybean, ononis, garlic, capsicum, chimpanzee, touki, seaweed, etc., activator (for example, royal jelly, photosensitizer, cholesterol derivative, etc.); blood circulation
- antiseborrheic agents eg, sulfur, thianthol, etc.
- anti-inflammatory agents eg, thiotaurine, Hypotaurine,
- Example I-1 Antibacterial effect
- the minimum growth inhibitory concentration (M I C) for various bacteria was determined.
- the following bacteria were inoculated on SCD agar medium (manufactured by Eiken) containing each of the following concentrations of 3-hexyne-2,5-diol at 30 ° C. After culturing for 4 hours, the concentration of 3-hexyne-2,5-diol which did not form colonies (minimum growth inhibitory concentration: MIC) was determined.
- concentration of 3-hexyne-2,5-diol which did not form colonies was determined.
- MIC minimum growth inhibitory concentration
- fungi the following fungi were inoculated on a potato dextrose agar medium containing 3-hexyne-1,2,5-diol at each concentration, and cultured at 25 ° C for 48 hours. —Hexin 1. The concentration of 2,5-diol (minimum inhibitory concentration: MIC) was determined. The same was done for methyl paraoxybenzoate. The judgment results are shown in Table 1 according to the following evaluation criteria.
- E Escherichia coli (strain name: EscherilichciacoliATCCC8739)
- Escherichia coli Bacteria name: Escherichia coli ATC
- Staphylococcus aureus (strain name: Staphylococc
- Candida albica strain name: Candida albica
- a safety test was performed on the 3-hexyne-2,5-diol of the present invention. As a result of a single dose toxicity test, the toxicity was judged to be extremely weak. In addition, as a result of a primary skin irritation test and a continuous skin irritation test, skin irritation was determined to be extremely weak. The results of skin sensitization test and genotoxicity test were negative. '
- each Example may be manufactured by a usual method for manufacturing each product, and only the compounding amount is shown.
- 1,3-butylene glycol 6 0 glycerin 4 0 oleyl alcohol 0
- Example I 1-4 Emulsion
- 1,3-butylene glycol cornole 30 sodium sodium edetate 0 2 methinolenolaven 0 0 1 purified water
- Example 1-7 Shampoo Lauryl polyoxyethylene (3) sulfate
- Example 1-12 Chinese noodle flour 98.0 Salt 1.0 Sweetener 0.5 3-Hexine-1,2,5-diol 0.5
- Example I-13 Mentsuyu liquid
- a lotion having the formulation shown in Table II-11 was prepared according to the following manufacturing method, and a use test and an antiseptic test were performed.
- the inoculum is mold (strain name: Aspergillus niger ATCC16404; inoculation amount 10 4 cfu (colony forming unit) / g), yeast
- strain name Candida albicans ATCC 10231; inoculum of 10 5 cfuZ g), Pakuteria
- E.coli Strain Name: Escherichia coli ATCC8739; inoculum size 10 6 cfu / g, Staphylococcus aureus: Strain Name: Staphylococcus aureus ATCC 6538; inoculum 10 6 cfu / g, Pseudomonas aeruginosa: strain name: Pseudomonas a eruginosa ATCC15442; inoculation amount 130.
- Remaining Remaining 7X Antiseptic test result AAADBA use test result A (10/10) A (9/10) A (8/10) B (7/10) CX4 / 10) B (6/10 ) Number of people who complained of irritation 0/10 0/10 0/10 0/10 1/10 4/10
- Example II-11, II-12 and II-13 no one complained of skin irritation, and the proportion of those who were satisfied with the usability was large and the preservative power was secured. This is an effect according to the present invention. Further, in Comparative Example II-1, the percentage of those who had little skin irritation and were satisfied with the usability was large, but the preservative power was poor. In Comparative Example II-2, there was no problem with the preservative power, but one person complained of skin irritation, which was considered to be due to poor useability and a large amount of ethanol. Comparative Example II-13 had excellent usability and antiseptic properties, but many people complained of skin irritation and had problems with skin irritation. Next, an emulsion 3 of the formulation shown in Table II-2. Was prepared according to the following method, and the use test and the preservative test were carried out in the same manner as described above. The results of the use test and the preservative test are shown in Table II-12. .
- Example II-14, II-15 and II-16 no one complained of skin irritation, and the proportion of those who were satisfied with the usability was large and the preservative power was secured. This is an effect according to the present invention.
- Comparative Example II-14 the proportion of those who satisfied the usability with little skin irritation was large, but the preservative power was poor.
- Comparative Example II-5 has excellent usability and antiseptic properties, but many people complained of skin irritation and had problems with skin irritation.
- a cream having the formulation shown in Table II-3 was prepared according to the following manufacturing method, and a use test and an antiseptic test were performed in the same manner as described above. The results of the use test and the antiseptic test are shown in Table II-13. .
- Example II-1-1 Lotion (Alcohol phase) ''
- Methylcellulose and quinceide were mixed with a part of the purified water and stirred to prepare a viscous liquid.
- the remaining purified water and other aqueous phase components were mixed and dissolved, and the above-mentioned viscous liquid was added thereto to obtain a uniform aqueous phase.
- Example I I 1-2 Cream
- the purified water was dissolved by adding propylene glycol and a hydration bead, and the mixture was heated and maintained at 70 ° C (aqueous phase).
- the other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase).
- the oil phase was gradually added to the water phase to pre-emulsify, uniformly emulsified with a homomixer, and then cooled to 30 ° C with thorough stirring.
- Example II- 1 14 Emulsion stearate 25 cetino-leano reconore 15 petrolatum 0.50 liquid paraffin 100
- the carboxyvinyl polymer was dissolved in a small amount of purified water (phase).
- phase purified water
- PEG150 and triethanolamine were added to the remaining purified water, and the mixture was heated and dissolved, and kept at 70 ° C (aqueous phase).
- the other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase).
- the oil phase was added to the water phase to carry out pre-emulsification.
- the phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C while stirring well.
- the carboxyvinyl polymer was uniformly dissolved in purified water (phase A).
- 95 POE (50) oleyl ether was dissolved in 95% ethanol and added to the A phase. After adding the components other than sodium hydroxide, sodium hydroxide was added to neutralize and thicken.
- phase A Dissolve the carboxyvinyl polymer in part of the purified water
- phase B dissolve potassium hydroxide in part of purified water
- phase C Dissolve the water-soluble components in purified water
- phase C Dissolve P0E (20) otatyl dodecanol and pantothenyl ethyl ether in ethanol, add phase C, mix and stir, mix phase A with this, then add phase B and then add homomixer. Stir and mix.
- Phases A, B, and C were uniformly dissolved, respectively, and phase B was added to phase A for solubilization. This was then added to phase C and mixed.
- Example II—19 Water-in-oil emulsification foundation
- the components (9) to (14) were uniformly mixed and dissolved, and the mixed and ground components (1) to (7) were added and dispersed. (8) was added to this dispersion to emulsify and filled into a container to obtain a water-in-oil emulsification foundation.
- Example II-200 White powder
- Titanium oxide coating my strength 50 (7) Screen 30
- Example II 24 Simphu % Lauryl polyoxyethylene (3) sulfate
- stearyl trimethylammonium chloride, glycerin, and dye to purified water and maintain at 70 ° C (aqueous phase), mix with other components, heat and dissolve and maintain at 70 ° C (oil phase). Add the oil phase to the water phase, emulsify with a homomixer, and cool with stirring.
- 1,3-butylene glycol cornole 20 erythritol 0 polyethylene glycol cornole 150 0 550 squalane '150 tetra 2-pentanoylhexanoate pentaerythritol 5 0 Hydroxidizing lithium 0
- a small amount of purified water can be used to prepare lipoxyvinyl polymer and acrylic acid.
- the water-soluble components were dissolved in the remaining purified water and heated to 70 ° C (aqueous phase).
- the oil component was mixed with the liquid oil, heated and melted, and kept at 70 ° C (oil phase).
- the oil phase was gradually added to the aqueous phase, pre-emulsification was performed, phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C with good stirring.
- Example II I-27 Cream Vaseline 20 Dimethylpolysiloxane (6 mPa.s) 20 Ethanol 50
- 1,3-Butylene glycol 50 Polyethylene glycol 2 0 0 0 0 0 5 Phosphon oil 3 0 Scotran 2 0 Phytosteryl hydroxystearate 0 5 Pentaerythroxy hexanoate 10 Polyoxyethylene (60) hydrogenated castor oil 10 Hydroxium hydroxide 0 1 Sodium bisulfite 0 0 1 Sodium hexamethacrylate 0 0 5 Stearyl glycyrrhetinate 0 1 Nontothene ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ 0
- phase A of carboxyvinyl polymer and xanthan gum dissolved in a small amount of purified water.
- the water-soluble components were dissolved in the remaining purified water and heated to 70 ° C (aqueous phase).
- the oil component was mixed with the liquid oil, heated and melted, and kept at 70 ° C (oil phase).
- the oil phase was gradually added to the water phase, pre-emulsification was performed, phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C while stirring well.
- Example II-28 Cream Decamethylcyclopentasiloxane 30.0 Polyoxyethylene / methylpolysiloxane copolymer
- Lithium mouth copolymer (molecular weight 550 000) 10 phenoxyethanol 20 sodium edetate 02 dimethyl distearyl ammonium hydrate 0 5 purified water-(process)
- phase of carboxyvinyl polymer dissolved in a small amount of purified water. Dissolve the water-soluble components in the remaining purified water and heat to 70 ° C (Aqueous phase). The oil component was mixed with the liquid oil, heated and melted, and kept at 70 ° C (oil phase). The oil phase was gradually added to the water phase, pre-emulsification was performed, phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C with thorough stirring.
- Test Example III-1 1 Antibacterial effect
- the minimum growth inhibitory concentration (MIC) for various bacteria was determined. The following tests were performed with 3-phenoxy-1,2-propanediol, 3-benzyloxy-1,2-propanediol, and methyl para-oxybenzoate.
- bacteria are inoculated on SCD agar medium (manufactured by Eiken) containing each test compound at each concentration and cultured at 30 ° C for 24 hours, and no colonies are formed.
- concentration of each test compound minimum growth inhibitory concentration: MIC
- fungi inoculate each of the following fungi on a potato dextrose agar medium containing each test compound at each concentration and incubate at 25 ° C for 48 hours. (Minimum growth inhibitory concentration: MIC) was determined. The judgment results are shown in Table 1 according to the following evaluation criteria.
- P s Green fungus Name: Pseudoma nasasaeruginoisa ATCCC1 5 4 4 2)
- E Escherichia coli (strain name: EschericlichiacoliiATCCC8739)
- C a n Candida (yeast) standard strain (strain name: C a n d i d a a a l b i c a n s A T C C 10 02 3 1)
- a sp Black mold (Strain name: A spergi 11 usniger ATCC 1 6 4 0 4)
- Minimum inhibitory concentration is less than 100 ppm
- Minimum growth inhibitory concentration is 100 ppm or more to less than 500 ppm
- Minimum growth inhibitory concentration is 500 ppm or more to less than 100 ppm
- the minimum growth inhibitory concentration is at least 1000 ppm to less than 300 ppm 5
- Minimum growth inhibitory concentration is more than 300 ppm
- Escherichia coli strain name: Escherichia col i ATC
- Staphylococcus aureus (strain name: Staphylococc
- Candida fungus (yeast) standard strain strain name:
- 3-Phenoxy-1,2-propanediole and 3-pendinoleoxy-1,2-pronole which are the glycerin derivatives of the present invention.
- a safety test was performed on Ngino Ile. As a result of a single dose toxicity test, the toxicity was judged to be extremely weak. In addition, as a result of the primary skin irritation test and the continuous skin irritation test, skin irritation was determined to be extremely weak. As a result of a skin sensitization test and a skin toxicity test, the result was negative.
- 1,3-butylene glycol cone 6 0 glycerin 4 0
- Example III-1 2 Lotion Ethanorone 5.0
- Example III-1 3 Lotion Ethanore 6 ⁇ 50
- Example III-16 Lotion Ethanol 4.0
- Example III-1 9 Emulsion
- 1,3-butylene glycol cornole 30 sodium edetate 0 2 phenoxyethanolen 0 0 2 purified water
- Example III-1-1 Emulsion
- 1,3_butylenglycorone 30 sodium sodium edetate 0 2 methinoparaben 0 0 1 purified water
- Glycerin monostearate 20 Tocopherol acetate 02 Monoammonium glycyrrhizinate 0 05 Glycerin 30 Dipropylene glycol Cornole 501,3-Butylene glycol 30 Phenoxyethanol 0 2 Triedate Sodium 0 0 1 Echinoreno ⁇ 0 Raven 0 1 Purified water
- Example I—II——13: Tari 3 - Benjiruokishi one 1, 2 - Purono ⁇ 0 Njioru 1 0 0 stearyl alcohol 3 5 stearic phosphate 2 0 Sukuwaran 1 0 5 Lee Sopuro Pirumi Li-state 7 5 Polyoxyethylene (POE 2 5) cetyl alcohol ether
- Glycerin monostearate 20 Tocopherol acetate 0 2 Monoammonium dalytyl litate 0 0 5 Glycerin 30 Dipropylene glycol cornole 501, 3 —Ptylenglyconele 30 Phenoethoxyethanol Nore '0 2 Trisodium edetate 0 0 1 Echinoreno laven 0 1 Purified water
- Example III-1-1 Face wash ft
- Example III-1-1 9 Shampoo lauryl polyoxyethylene (3) sulfate
- Example III 21 Jelly pack 3 —Phenoxy-1,2 —propanediole 0 1 Polyethylene ethylene alcohol alcohol 0 5 Monoammonium glycyrrhizinate 0 0 5 Canoleboxymethinoresolesolose 5 0 Ethanol 1 +2 0 Poly Bulanolecone 1 2 0 1, 3 —Butylendalcol 50 0 Trisodium edetate 0 0 1 Purified water
- Example III-28 Hair Tonic Hardened Castor Oil Ethylene Oxide (40 Mol) Adduct 2.0 Ethanore 60.0 Perfume
- Example III-30 Bath agent sodium bicarbonate 60.0 sodium sulfate anhydrous 3.5.0
- Mass% flour 9 0.0 salt 2 sugar 2 0 water 6 0
- Example III-45 Ground ham 95.0 Chicken egg 4.0 Salt 0.5 Spice 0.4
- a lotion having the formulation shown in Table IV-1 was prepared according to the following manufacturing method, and a use test and an antiseptic test were performed.
- Examples 1, 2, and 3 were prepared by adding 3-phenoxy_1, .2-propanediol to purified water.
- Examples 4, 5, and 5 were obtained by adding 3-benzyloxy-1,2-propanediol. It was 6. They dissolve citrate, trisodium citrate and trisodium edetate, respectively (aqueous phase). Dissolve ethanol, glycerin, 1,3-butylene glycol, POE (60) hydrogenated castor oil, and methylparaben (alcohol phase). Mix the aqueous and alcohol phases.
- Inoculum fungus strain name: Aspergillus niger ATCC 16404; inoculum size 10 4 cfu (colony forming unit) / g), yeast (strain name: Candida albicans ATCC 10231; inoculum size 10 5 cfu / g), Pakuteria (E.coli: Strain name : Escherichia coli ATCC8739; inoculation of 10 6 cfu / g, Staphylococcus aureus: strain name: Staphylococcus aur eus ATCC6538; inoculum size 10 6 cfu / g, Pseudomonas aeruginosa: strain name: Pseudomona s aeruginosa ATCC15442; inoculum 10
- a or B is judged to be acceptable as the preservative power of the skin external preparation composition.
- the results of use test and preservative test are shown in Table IV-1.
- Example IV-1 to 6-6 no one complained of skin irritation, and the percentage of those who were satisfied with the usability was large and the preservative power was secured. This is the effect of the present invention.
- Comparative Example IV-1 the percentage of those who were satisfied with the usability with little skin irritation was large, but the preservative power was poor.
- Comparative Example I-2 there was no problem with antiseptic activity, but one person complained of skin irritation, which was considered to be caused by poor satisfaction in use and a large amount of ethanol.
- Comparative Example IV-3 has excellent usability and antiseptic properties, but many people complained of skin irritation and had problems with skin irritation.
- Milk 5 having the formulation shown in IV-2 was prepared according to the following production method, and the use test and the preservative test were carried out in the same manner as described above. The results of the use test and the preservative test are shown in Table IV-2. .
- Examples IV-7, IV-8, and IV-9 were prepared by adding 3_phenoxy_1,2-propanediol to purified water, and were prepared by adding 3_benzyloxy_1,2-propanediol. 10, 1 1, 1 2 were used.
- the oil phase is added to the water phase, pre-emulsified, homogenized with a homomixer, and cooled.
- Example IV-7 to IV-12 no one complained of skin irritation, and the proportion of those who were satisfied with the usability was large and the preservative power was secured. This is an effect according to the present invention.
- Comparative Example IV-4 the proportion of those who satisfied the usability with little skin irritation was large, but the preservative power was poor.
- Comparative Example IV-5 had excellent usability and antiseptic properties, but many complained of skin irritation and had problems with skin irritation.
- Table IV-.3 shows the results of the tests and preservative tests.
- Examples 13 to 14 were prepared by adding 3-phenoxy-1,2-propanediol to purified water, and Examples were obtained by adding 3-benzyloxy_1, 2-propanediol.
- IV—16, IV—17, and IV—18. Add 1,3-butylene glycol and propylene glycol to each, and heat to 7 ° C (aqueous phase). After heating and dissolving stearyl alcohol, stearyl acid, hydrogenated lanolin, squalane, and octyl decanol, add POE (25) cetyl alcohol ether, glyceryl monostearate, and methylparaben and adjust to 70 ° C. Yes (oil phase). Add oil phase to water phase, emulsify with homomixer and cool.
- a viscous liquid was prepared by mixing methyl cellulose and quince seed into a part of the purified water and stirring. The remaining purified water and other aqueous phase components were mixed and dissolved, and the above-mentioned viscous liquid was added thereto to obtain a uniform aqueous phase. After preparation of the alcohol phase, it was added to the aqueous phase and mixed.
- a viscous liquid was prepared by mixing methyl cellulose and quince seed into a part of the purified water and stirring. The remaining portion of the purified water and other aqueous phase components were mixed and dissolved, and the above-mentioned viscous liquid was added thereto to obtain a uniform aqueous phase. After preparing an alcohol phase, the alcohol phase was added to the aqueous phase and mixed.
- Methylcellulose and quinceide were mixed with a part of the purified water and stirred to prepare a viscous liquid.
- the remaining portion of the purified water and the other aqueous phase components were mixed and dissolved, and the above-mentioned viscous liquid was added thereto to obtain a homogeneous aqueous phase.
- Ethanorone 50 Ethynolehexanediole 0 2 POE (20) Oleyl ether 0 53 3 _Phenoxy-1,2, propanediol 0 5 3 _Benzyloxy 1,2-propanediol 0 52 2, 2-Jetyl 1, 3- Propanediole 0 1 2,2,4_ Trimethyl-1,3-pentanediol 0 5 Phenyloxyethanol 0 Methi ⁇ / paraben 0 Fragrance
- a viscous liquid was prepared by mixing methyl cellulose and quince seed into a part of the purified water and stirring. The remaining purified water and other aqueous phase components were mixed and dissolved, and the above-mentioned viscous liquid was added thereto to obtain a uniform aqueous phase.
- Stearinic acid 50 Stearyl oleorenoate 40 0
- Isopropyl myristate 80 Glycerin monostearate 30
- the purified water was dissolved by adding propylene glycol and lithium hydroxide, and heated to 70 ° C (aqueous phase). Mix other ingredients, heat and melt The temperature was kept at 70 ° C (oil phase). The oil phase was gradually added to the water phase to pre-emulsify, uniformly emulsified with a homomixer, and cooled to 30 ° C with thorough stirring.
- Mass% stearic acid 6.0 sonolebitan monostearate estenolate 20 POE (20) sorbitan monostearate 5 propylene glycol cornole 9 ⁇ 6 1 0 0
- Example IV—2_8 Cream
- the carboxyvinyl polymer was dissolved in a small amount of purified water (phase).
- phase purified water
- PEG150 and triethanolamine were added to the remaining purified water, and the mixture was heated and dissolved, and kept at 70 ° C (aqueous phase).
- the other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase).
- the oil phase was added to the water phase to carry out pre-emulsification.
- the phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C while stirring well.
- phase A The lipoxyvinyl polymer was dissolved in a small amount of purified water (phase A). PEG 150 and triethanolamine were added to the remaining purified water, and the mixture was dissolved by heating and kept at 70 ° C (aqueous phase). The other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase). The oil phase was added to the water phase to carry out pre-emulsification. The phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C while stirring well.
- phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C while stirring well.
- Example IV—32 Emulsion Mass% stearyl acid 2.5 cetyl alcohol 5 ethynolehexanediole 10
- the carboxybutyl polymer was dissolved in a small amount of purified water (phase A).
- phase A purified water
- PEG150 and triethanolamine were added to the remaining purified water, and the mixture was heated and dissolved, and kept at 70 ° C (aqueous phase).
- the other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase).
- the oil phase was added to the water phase to perform pre-emulsification, and then the phase A was added, and the mixture was uniformly emulsified with a homomixer.
- Vaseline 1 5 Liquid paraffin 0 0
- the carboxybutyl polymer was dissolved in a small amount of purified water (phase).
- phase purified water
- PEG150 and triethanolamine were added to the remaining purified water, and the mixture was dissolved by heating and kept at 70 ° C (aqueous phase).
- the other ingredients were mixed, heated and melted and kept at 70 ° C (oil phase).
- the oil phase was added to the water phase to perform pre-emulsification, and then the phase A was added, and the mixture was uniformly emulsified with a homomixer.
- the carboxybutyl polymer was uniformly dissolved in purified water (phase). 95 POE (50) oleyl ether was dissolved in 95% ethanol and added to the A phase. After adding components other than sodium hydroxide, sodium hydroxide was added to neutralize and thicken.
- the carboxyvinyl polymer was uniformly dissolved in purified water (phase A).
- 95 POE (50) oleyl ether was dissolved in 95% ethanol and added to the A phase. After adding components other than sodium hydroxide, sodium hydroxide is added.
- the carboxyvinyl polymer was uniformly dissolved in purified water (phase A).
- 95 POE (50) oleyl ether was dissolved in 95% ethanol and added to the A phase. After adding components other than sodium hydroxide, sodium hydroxide was added to neutralize and thicken.
- the carboxybutyl polymer was uniformly dissolved in purified water (phase A). 9 Dissolve P0E (50) oleyl ether in 5% ethanol and add to phase A. Added. After adding components other than sodium hydroxide, sodium hydroxide was added to neutralize and thicken.
- Dissolve the lipoxyvinyl polymer in a part of the purified water phase.
- dissolve potassium hydroxide in part of the purified water B phase.
- Dissolve the water-soluble components in the remaining purified water phase C.
- phase A Dissolve the carboxyvinyl polymer in part of the purified water
- phase B dissolve potassium hydroxide in part of the purified water
- phase C Dissolve the water-soluble components in the remaining purified water
- the P0E (20) octyl dodecanol and pantothenyl ethyl ether were dissolved in ethanol, the above-mentioned phase C was added thereto, and the mixture was stirred.
- the phase A was stirred and mixed, and then the phase B was added, followed by stirring and mixing with a homomixer.
- phase A Dissolve carboxybutyl polymer in part of purified water
- phase B dissolve the hydration power in a part of the purified water
- phase C Dissolve the water-soluble components in the remaining purified water
- phase C Dissolve P0E (20) octinole dodecanol and pantothenyl ethyl ether in ethanol, add the above phase C, mix and stir, add phase A to this, stir and mix, then add phase B, and stir and mix with a homomixer. did. .
- Phase A mass% dipropylene glycol 5.0 5.0 POE (60) hydrogenated castor oil 5.0
- Phase B mass% olive oil 5.0 Tocopherol acetate 0.2 Fragrance 0.2
- Phases A, B, and C were uniformly dissolved, respectively, and phase B was added to phase A for solubilization. This was then added to phase C and mixed.
- Phases A, B, and C were uniformly dissolved, respectively, and phase B was added to phase A for solubilization. This was then added to phase C and mixed.
- Example IV__44 Water-in-oil emulsification foundation
- the components (9) to (17) were uniformly mixed and dissolved, and the mixed and ground components (1) to (7) were added and dispersed. (8) was added to this dispersion to emulsify and filled into a container to obtain a water-in-oil emulsification foundation.
- Example IV—45 Water-in-oil emulsification termination
- the components (9) to (22) were uniformly mixed and dissolved, and the mixed and ground components (1) to (7) were added and dispersed. (8) was added to this dispersion to emulsify and filled into a container to obtain a water-in-oil emulsification foundation.
- Example IV—47 White powder
- Liquid paraffin 6 10 Setinoleanone cone 15 Stearyl alcohol 0 Stearyl trimethylammonium chloride 0 7 3 —Phenoxy-1,2, -Pronondiol 503 —Benzyloxy_1,2 Pronondione Nore 50 Glycerin 30 Dye
- Liquid paraffin 100 Dimethyl polysiloxane 20 Glycerin 1 0 0
- phase A Make a solution (phase A) of a carboxyvinyl polymer and acrylic acid / alkyl methacrylate copolymer dissolved in a small amount of purified water.
- the water-soluble components were dissolved in the remaining purified water and heated to 70 ° C (aqueous phase).
- the oil component was mixed with the liquid oil, heated and melted and kept at 70 ° C (oil phase) .
- the oil phase was gradually added to the aqueous phase, pre-emulsification was performed, phase A was added, and the mixture was uniformly emulsified with a homomixer and cooled to 30 ° C with good stirring.
- Example IV—54 Cream Vaseline • 20 Dimethylpolysiloxane (6 mPa.s) 20 Ethanore 50 0 ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ ⁇ 5 5 0 5 Glycerin 70
- phase A Make a solution (phase A) of lipoxyvinyl polymer and xanthan gum dissolved in a small amount of purified water. 'The water-soluble components were dissolved in the remaining purified water and heated to 70 ° C (aqueous phase). The oil component was mixed with the liquid oil, heated and melted, and kept at 70 ° C (oil phase). The oil phase was gradually added to the water phase, pre-emulsification was performed, phase A was added, and the mixture was uniformly emulsified with a homomixer, and then cooled to 30 ° C with good stirring.
- Phenyloxyethanol 2 0.2 Methyl paraben 0.1 sodium edetate 0.02 dimethyl distearyl ammonium chloride 0.5 Purified water remaining
- the polyoxyethylene, methylpolysiloxane copolymer, poly (oxyethylene 'oxypropylene)' methylpolysiloxane copolymer, dimethyldistearylammonium heptrite and other oily components are removed.
- the temperature is adjusted to 70 ° C, and the mixture is uniformly dispersed and dissolved to obtain an oily gel.
- Add glycerin, dipropylene glycol and 3_phenoxy-1,2-propanediol was gradually added to the oily gel with stirring, mixed uniformly with a homomixer, and cooled to 30 ° C.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Agronomy & Crop Science (AREA)
- Pest Control & Pesticides (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Cosmetics (AREA)
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/551,416 US20060257436A1 (en) | 2003-04-04 | 2004-04-02 | Skin preparation composition for external use |
EP04725508A EP1614351A1 (en) | 2003-04-04 | 2004-04-02 | Skin preparation composition for external use |
Applications Claiming Priority (14)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003102326A JP4953409B2 (ja) | 2003-04-04 | 2003-04-04 | 抗菌剤 |
JP2003-102326 | 2003-04-04 | ||
JP2003102456A JP2004307386A (ja) | 2003-04-07 | 2003-04-07 | 皮膚外用組成物 |
JP2003-102456 | 2003-04-07 | ||
JP2003371241A JP4349883B2 (ja) | 2003-10-30 | 2003-10-30 | 皮膚外用組成物 |
JP2003371240A JP2005132777A (ja) | 2003-10-30 | 2003-10-30 | 抗菌剤 |
JP2003-371240 | 2003-10-30 | ||
JP2003-371241 | 2003-10-30 | ||
JP2003-422035 | 2003-12-19 | ||
JP2003422035A JP4301499B2 (ja) | 2003-12-19 | 2003-12-19 | 皮膚外用組成物 |
JP2003428532A JP2005187351A (ja) | 2003-12-25 | 2003-12-25 | 抗菌剤 |
JP2003-428532 | 2003-12-25 | ||
JP2004026349A JP2005220026A (ja) | 2004-02-03 | 2004-02-03 | 抗菌剤 |
JP2004-026349 | 2004-02-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004089087A1 true WO2004089087A1 (ja) | 2004-10-21 |
Family
ID=33163293
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2004/004826 WO2004089087A1 (ja) | 2003-04-04 | 2004-04-02 | 皮膚外用剤組成物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US20060257436A1 (ja) |
EP (1) | EP1614351A1 (ja) |
KR (1) | KR20060006796A (ja) |
TW (1) | TW200509970A (ja) |
WO (1) | WO2004089087A1 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093329A1 (ja) * | 2005-03-03 | 2006-09-08 | Shiseido Company, Ltd. | 抗菌剤 |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0609749A2 (pt) * | 2005-04-07 | 2011-10-18 | Chata Biosystems | sistema de acondicionamento de caminho de fluxo |
US8119688B2 (en) * | 2007-09-19 | 2012-02-21 | Xy, Llc | Differential evaporation potentiated disinfectant system |
US20100249166A1 (en) | 2007-09-19 | 2010-09-30 | Xy, Inc. | Differential evaporation potentiated disinfectant system |
US9327144B2 (en) * | 2009-03-13 | 2016-05-03 | Elc Management Llc | Powder compositions containing edible grains |
US20120152149A1 (en) * | 2009-08-26 | 2012-06-21 | Basf Se | Use of 1,3-diols as biocides |
JP4837086B2 (ja) * | 2009-12-15 | 2011-12-14 | 株式会社 資生堂 | 乳化化粧料 |
KR20130027860A (ko) | 2011-09-08 | 2013-03-18 | 현대자동차주식회사 | 컴플라이언스 특성이 개선된 ctba |
CN111700886A (zh) * | 2020-04-23 | 2020-09-25 | 广州宏康医药科技有限公司 | 一种复方大蒜素软胶囊及其制备包装方法 |
EP4236907A4 (en) * | 2020-10-30 | 2024-07-24 | Oreal | COMPOSITION FOR SKIN CARE |
WO2024173564A1 (en) * | 2023-02-15 | 2024-08-22 | American Sterilizer Company | Quaternary ammonium based broad spectrum disinfectant |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1028443A (en) * | 1964-01-29 | 1966-05-04 | Gillette Co | Antiperspirant composition for topical application |
-
2004
- 2004-04-02 TW TW093109288A patent/TW200509970A/zh unknown
- 2004-04-02 EP EP04725508A patent/EP1614351A1/en not_active Withdrawn
- 2004-04-02 US US10/551,416 patent/US20060257436A1/en not_active Abandoned
- 2004-04-02 WO PCT/JP2004/004826 patent/WO2004089087A1/ja not_active Application Discontinuation
- 2004-04-02 KR KR1020057018902A patent/KR20060006796A/ko not_active Application Discontinuation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1028443A (en) * | 1964-01-29 | 1966-05-04 | Gillette Co | Antiperspirant composition for topical application |
Non-Patent Citations (1)
Title |
---|
VON REISCH J. ET AL: "Zur Frage der mikrobiologischen Wirksamkeit einfacher Acetylen-Verbindungen", ARZNEIMITTEL-FORSCHUNG, vol. 17, no. 7, 1967, pages 816 - 825, XP002026089 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006093329A1 (ja) * | 2005-03-03 | 2006-09-08 | Shiseido Company, Ltd. | 抗菌剤 |
Also Published As
Publication number | Publication date |
---|---|
US20060257436A1 (en) | 2006-11-16 |
EP1614351A1 (en) | 2006-01-11 |
TW200509970A (en) | 2005-03-16 |
KR20060006796A (ko) | 2006-01-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101455969B1 (ko) | 피부 외용제 | |
JP4573690B2 (ja) | 化粧料用油剤又は皮膚外用剤用油剤、並びに化粧料又は皮膚外用剤 | |
JP4968889B2 (ja) | 皮膚外用組成物 | |
WO2020147953A1 (en) | An antimicrobial mixture | |
JP2009275017A (ja) | バイオサーファクタント含有水中油型乳化化粧品組成物 | |
JP2010018560A (ja) | バイオサーファクタント含有油中水型乳化化粧品組成物 | |
WO2014115726A1 (ja) | 抗菌性組成物 | |
WO2004089087A1 (ja) | 皮膚外用剤組成物 | |
JP2008247839A (ja) | カルコン配糖体を含む抗酸化剤 | |
JP5754796B2 (ja) | 抗酸化剤及びその利用 | |
JP2011001313A (ja) | バイオサーファクタント及び界面活性剤を含有する組成物 | |
JP2009149566A (ja) | バイオサーファクタントを含有する化粧品組成物 | |
JP2006249049A (ja) | 皮膚外用組成物 | |
JP2010018559A (ja) | バイオサーファクタントを含有する化粧品組成物 | |
JP2011001312A (ja) | バイオサーファクタント及び多価アルコールを含有する組成物 | |
JP2010043041A (ja) | 化粧品組成物 | |
JP2009167158A (ja) | バイオサーファクタントを含有する化粧品組成物 | |
JP2009149567A (ja) | バイオサーファクタントを含有する化粧品組成物 | |
JP2015048321A (ja) | セロビオースリピッド及び美白剤を含有する化粧料組成物 | |
JP2011001314A (ja) | バイオサーファクタント及び抗炎症剤を含有する組成物 | |
JP2010018584A (ja) | ポリ−γ−L−グルタミン酸および/またはその塩を含有する化粧品組成物 | |
JP2015048319A (ja) | セロビオースリピッド及び保湿剤を含有する化粧料組成物 | |
JP2005132778A (ja) | 皮膚外用組成物 | |
JP2011105607A (ja) | バイオサーファクタントを有効成分とするアレルギー反応遅発相抑制剤 | |
JP2010018582A (ja) | ポリ−γ−L−グルタミン酸および/またはその塩を含有する化粧品組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 20048087974 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006257436 Country of ref document: US Ref document number: 10551416 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004725508 Country of ref document: EP Ref document number: 1020057018902 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 2004725508 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057018902 Country of ref document: KR |
|
WWP | Wipo information: published in national office |
Ref document number: 10551416 Country of ref document: US |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2004725508 Country of ref document: EP |